
-
NFkB p65 (C20) Blocking Peptide
NFkB p65 (C20) Blocking Peptide
- 中文名称:
- NFkB p65 (C20) Blocking Peptide
- 英文名称:
- NFkB p65 (C20) Blocking Peptide
- 品牌:
- AAA Biotech
- 品牌介绍:
- AAA Biotech专注于为全球生命科学研究提供高品质的蛋白质研究工具,核心产品包括经严格验证的抗体、重组蛋白及ELISA试剂盒。
- 货号:
- AAA63036
- 规格:
- 0.1 mg|2x0.1 mg|3x0.1 mg|5x0.1 mg|4x0.1 mg
- 保存建议:
- Store this product at 4º C, do not freeze. The product is stable for one year from the date of shipment.
- 货期:
- 6-8周
- 纯度:
- N/A
- 产品形式:
- Each vial contains 200 ug/ml of affinity-purified rabbit IgG, NFκB p65 MBS443031 (C20), in 1 ml PBS containing 0.1 % sodium azide and 0.2% gelatin.
- 免责声明:
- *本产品仅供科研实验使用,不得用于临床诊断。*
- 说明书:
Background: Members of the rel/NFκB family of transcription factors are involved in the regulation of cellular responses, such as growth, development, and the inflammatory response. They share a structural motif known as the rel homology region (RHR), the C-terminal one third of which mediates protein dimerization. Complexes of p50 (NF-κB1) or p52 (NF-κB2) are generated through the processing of p105 and p100 precursors, respectively. These are usually associated with members of the Rel family (p65, c-Rel, Rel B). The homo- and heterodimer formed through combinations of NFκB/Rel proteins bind distinct κB sites to regulate the transcription of different genes. In resting cells, NFκB is retained in the cytoplasm bound to inhibitory proteins of the IκB family. Degradation of IκB proteins occurs with cell activation, via of variety of signals, including inflammatory cytokines and bacterial lipopolysaccharides (LPS) as well as oxidative and fluid mechanical stress. This results in nuclear translocation of NFκB and the transcriptional gene activation of proinflammatory genes. It has been suggested that NFκB plays a role in the development of numerous pathological states. Activation of NFκB induces gene programs leading to transcription of factors that promote inflammation, such as leukocyte adhesion molecules, cytokines, and chemokines. It is also thought that there are some substances with possible anti-inflammatory effects that are also NFκB regulated. There is some evidence indicating NFκB as a key factor in the pathophysiology of cardiac ischemia-reperfusion injury as well as the development of insulin dependent Diabetes Mellitus.